Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc Analysis
To our knowledge, this is the first analysis to explore the relationship between DL<sub>CO</sub> and mortality risk in patients with ASMD type B and type A/B. Overall, these findings underscore how DL<sub>CO</sub> affects the mortality risk in patients with ASMD.
Authors
- Ruth Pulikottil-Jacob (ORCID: https://orcid.org/0000-0003-0630-960X)
- Marie Fournier (ORCID: https://orcid.org/0000-0002-3805-1706)
- Wim Wuyts (ORCID: https://orcid.org/0000-0002-4349-9038)
- V. Kapetanakis
- Maurizio Scarpa
- Maja Gašparić
- Pragya Shukla
Institutions
- University of Udine (IT)
- Sanofi (France) (FR)
- Ruhrlandklinik (DE)
- Sanofi (Netherlands) (NL)
- IMEC (BE)
- EVRAZ (United Kingdom) (GB)
- Sanofi (United Kingdom) (GB)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1007/s12325-025-03481-4
- Primary Topic
- Heme Oxygenase-1 and Carbon Monoxide
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi